David Allan Barr
Chief Executive Officer at PENDER GROWTH FUND INC.
Net worth: 1 M $ as of 30/03/2024
Profile
Mr. David A.
Barr, CFA MBA, is a Chief Executive Officer & Portfolio Manager at PenderFund Capital Management Ltd., a President, Chief Executive Officer & Director at Pender Growth Fund, Inc. and a President, CEO and Portfolio Manager at Pender Private Equity Fund Management, Inc. He is on the Board of Directors at Pender Growth Fund, Inc.
Mr. Barr also served on the board at Chromos Molecular Systems, Inc. and one45 Software, Inc.
He holds a Bachelor of Science degree from the University of British Columbia and an MBA from the Schulich School of Business.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
PENDER GROWTH FUND INC.
3.34% | 17/05/2023 | 251,469 ( 3.34% ) | 1 M $ | 30/03/2024 |
David Allan Barr active positions
Companies | Position | Start |
---|---|---|
PENDER GROWTH FUND INC. | Chief Executive Officer | 31/10/2006 |
Pender Private Equity Fund Management, Inc.
Pender Private Equity Fund Management, Inc. Investment ManagersFinance Pender Private Equity Fund Management Inc (Pender Ventures) is a venture capital subsidiary of PenderFund Capital Management Ltd founded in 1994 by John Kelly Edmison. The firm is headquartered in Vancouver, Canada with an office in Ontario. | Chief Executive Officer | 31/03/2016 |
PenderFund Capital Management Ltd.
PenderFund Capital Management Ltd. Investment ManagersFinance PenderFund Capital Management Ltd. (Pender) is an independent, value-based mutual fund firm headquartered in Vancouver, Canada. The firm was founded by J. Kelly Edmison in 2003. Pender manages a range of funds for various types of clients. | Chief Executive Officer | 31/03/2016 |
Former positions of David Allan Barr
Companies | Position | End |
---|---|---|
Chromos Molecular Systems, Inc.
Chromos Molecular Systems, Inc. BiotechnologyHealth Technology Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology | Director/Board Member | 18/03/2007 |
one45 Software, Inc.
one45 Software, Inc. Packaged SoftwareTechnology Services one45 Software, Inc. provides educational software solutions for healthcare institutions. It offers a suite of software tools for managing, scheduling, assessing, and tracking medical education programs. The company was founded by Ric Arseneau, Derek Hemmes, and John Simms in 2001 and is headquartered in Vancouver, Canada. | Director/Board Member | - |
Training of David Allan Barr
York University | Masters Business Admin |
University of British Columbia | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Chromos Molecular Systems, Inc.
Chromos Molecular Systems, Inc. BiotechnologyHealth Technology Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology | Health Technology |
Pender Growth Fund, Inc.
Pender Growth Fund, Inc. Financial ConglomeratesFinance Pender Growth Fund, Inc. is a diversified venture capital fund that invests in technology companies within the province of British Columbia with the objective of long-term capital appreciation. The fund focuses on expansion and restructuring opportunities within the technology sector that offer investors the potential for liquidity through either existing public listings or near term liquidity events. Pender Growth Fund was founded on March 7, 1994 and is headquartered in Vancouver, Canada. | Finance |
Pender Private Equity Fund Management, Inc.
Pender Private Equity Fund Management, Inc. Investment ManagersFinance Pender Private Equity Fund Management Inc (Pender Ventures) is a venture capital subsidiary of PenderFund Capital Management Ltd founded in 1994 by John Kelly Edmison. The firm is headquartered in Vancouver, Canada with an office in Ontario. | Finance |
one45 Software, Inc.
one45 Software, Inc. Packaged SoftwareTechnology Services one45 Software, Inc. provides educational software solutions for healthcare institutions. It offers a suite of software tools for managing, scheduling, assessing, and tracking medical education programs. The company was founded by Ric Arseneau, Derek Hemmes, and John Simms in 2001 and is headquartered in Vancouver, Canada. | Technology Services |
PenderFund Capital Management Ltd.
PenderFund Capital Management Ltd. Investment ManagersFinance PenderFund Capital Management Ltd. (Pender) is an independent, value-based mutual fund firm headquartered in Vancouver, Canada. The firm was founded by J. Kelly Edmison in 2003. Pender manages a range of funds for various types of clients. | Finance |
- Stock Market
- Insiders
- David Allan Barr